WISC 2016 - World Allergy Organization
←
→
Page content transcription
If your browser does not render page correctly, please read the page content below
WISC 2016
WAO INTERNATIONAL SCIENTIFIC CONFERENCE 2016
6-9 December 2016
Jerusalem, Israel
Outstanding Allergy, Clinical Immunology and Cultural Heritage
PRELIMINARY PROGRAM
Registration
and Abstract
Submission
Now Open!
www.worldallergy.org/wisc2016
www.facebookcom/worldallergyorg @worldallergy
A meeting of the In collaboration with and their mutually collaborating partner
Invitation to Participate
Dear Colleagues,
We are delighted to invite you to participate in the WAO International Scientific Conference (WISC 2016) in Jerusalem, Israel,
6-9 December 2016. The theme of the Conference is Outstanding Allergy, Clinical Immunology and Cultural Heritage.
As a global alliance of national and regional allergy, asthma and clinical immunology societies, WAO is proud to partner with
the Israel Association of Allergy and Clinical Immunology (IAACI) and their mutually collaborating partner Allergists for Israel
(AFI) to host WISC 2016.
The WAO International Scientific Conference has grown and evolved from one edition to the next, and the meeting in
Jerusalem will continue to build on the hugely successful preceding Conferences in Dubai, United Arab Emirates (2010),
Hyderabad, India (2012), and Rio de Janeiro, Brazil (2014). Delegates may count on a diverse and stimulating scientific
program, highly relevant to both the theory and practice of allergy, asthma and clinical immunology.
WAO organizes these scientific Conferences in recognition of:
• The increasing prevalence and more complex forms of allergic diseases and asthma worldwide, especially in children
• The need to create a more integrated approach to the diagnosis and management of allergic diseases and asthma
• The need to expand the knowledge and practice of allergy and provide more practical knowledge to young professionals
The 2016 Conference on Outstanding Allergy, Clinical Immunology and Cultural Heritage will provide a forum for the most
useful combination of the latest research, review of current theory and practice, and hands-on, problem-based learning. Our
aim is that participants gain insight into the most effective advances in the diagnosis and management of complex and severe
allergies and asthma and in their preventive strategies.
We look forward to seeing you in Jerusalem, Israel!
Mario Sánchez Borges Ignacio J. Ansotegui Lanny J. Rosenwasser Nancy Agmon-Levin Jonathan A. Bernstein
WAO President Conference WAO President-Elect WAO Past-President IAACI President AFI President
President Conference Chair Chair, Local Organizing
Committee
Abstract Submission and Online Registration Now Open!
Check the Conference website for frequent updates: www.worldallergy.org/wisc2016
TABLE OF CONTENTS
About WAO................................................................................ 2 Program At-A-Glance................................................................. 6
About IAACI................................................................................ 2 WISC 2016 Keynote Speakers.................................................. 10
About AFI................................................................................... 2 Preliminary Scientific Program—Tuesday, 6 December.......... 12
Conference Information............................................................ 3 Preliminary Scientific Program—Wednesday, 7 December.... 14
Scientific Program Information.................................................. 3 Preliminary Scientific Program—Thursday, 8 December........ 16
What-to-Know . ......................................................................... 4 Preliminary Scientific Program—Friday, 9 December............. 18
Abstract Submission – Now Open!............................................ 5 Registration.............................................................................. 19
Accommodations..................................................................... 20
WISC 2016 6-9 December 2016 Jerusalem, Israel 1
About WAO
The World Allergy Organization (WAO) is an international alliance of 97 regional and national allergy,
asthma and clinical immunology societies. Through collaboration with the Member Societies,
WAO provides a wide range of educational and outreach programs, symposia and lectureships
to allergists/immunologists around the globe and conducts initiatives relating to clinical practice,
service provision, and physician training in order to better understand and address the challenges
facing allergists/immunologists worldwide.
About IAACI
The Israel Association for Allergy and Clinical Immunology (IAACI), founded in 1949, is a non-profit
association, with a mission to promote education, good clinical practice and research in a wide
spectrum of allergic and immune mediated diseases in Israel, under the umbrella of the Israel Medical
Association (IMA). The IAACI is dedicated to promoting collaborations between Allergists/Clinical
Immunologists and physicians from other disciplines in Israel, aiming to expand knowledge and
improve patient care. This is achieved by promoting joint meetings and producing Israeli collaborative
recommendations on various topics.
About AFI
Allergists for Israel (AFI) was founded in 1984 and the evolving vision of the group is to develop
camaraderie of Allergists/Immunologists and other supporters of allergy by gathering in the USA,
Israel and around the world. AFI strives to establish collegial relations between America and Israel.
2016-2017 WAO
BOARD OF DIRECTORS CONFERENCE COMMITTEES
Mario Sánchez Borges, President, Venezuela Conference President Lanny J. Rosenwasser, United States
Ignacio J. Ansotegui, President-Elect, Spain Mario Sánchez Borges, Venezuela Mario Sánchez Borges, Venezuela
Motohiro Ebisawa, Secretary-General, Japan William Silvers, United States
Steering Committee
Francesca Levi-Schaffer, Treasurer, Israel Mario Zernotti, Argentina
Nancy Agmon-Levin, Israel
Lanny J. Rosenwasser, Past-President, United
Ignacio J. Ansotegui, Spain Scientific Program Committee
States
Jonathan A. Bernstein, United States Ignacio J. Ansotegui, Co-Chair, Spain
Ruby Pawankar, Historian, Japan
Leonard Bielory, United States Claus Bachert, Co-Chair, Belgium
Mübeccel Akdis, Switzerland
Motohiro Ebisawa, Japan Jonathan A. Bernstein, Co-Chair, United States
Suwat Benjaponpitak, Thailand
Aharon Kessel, Israel Nancy Agmon-Levin, Israel
Sergio Bonini, Italy
Ruby Pawankar, Japan Mübeccel Akdis, Switzerland
Wesley Burks, United States
Lanny J. Rosenwasser, United States Leonard Bielory, United States
Luis Caraballo, Colombia
Menachem Rottem, Israel Sergio Bonini, Italy
Zeinab Awad El-Sayed, Egypt
Mario Sánchez Borges, Venezuela Wesley Burks, United States
Stanley Fineman, United States
Paul Greenberger, United States Luis Caraballo, Colombia
Local Organizing Committee
Elham Hossny, Egypt Ilan Dalal, Israel
Nancy Agmon-Levin, Chair, Israel
Jose Antonio Ortega-Martell, Mexico Motohiro Ebisawa, Japan
Ilan Dalal, Israel
Hirohisa Saito, Japan Roy Gerth van Wijk, Netherlands
Alon Hershko, Israel
Mimi Tang, Australia Edgardo Jares, Argentina
Yitzhak Katz, Israel
Mario Zernotti, Argentina Yitzhak Katz, Israel
Aharon Kessel, Israel
Luo Zhang, China Gideon Lack, United Kingdom
Yossi Mekori, Israel
Francesca Levi-Schaffer, Israel
Menachem Rottem, Israel
2013-2016 IAACI Valery Teplitsky, Israel
Richard Lockey, United States
BOARD OF DIRECTORS Dean Metcalfe, United States
Organizing Committee Josh Milner, United States
Nancy Agmon-Levin, President, Israel Ignacio J. Ansotegui, Spain Ruby Pawankar, Japan
Ilan Dalal, Past President, Israel Jonathan A. Bernstein, United States Susan Prescott, Australia
Aharon Kessel, Secretary, Israel Motohiro Ebisawa, Japan Nelson Rosário Filho, Brazil
Valery Teplitsky, Treasurer, Israel Stanley Fineman, United States Lanny J. Rosenwasser, United States
Alon Hershko, Member, Israel Roy Gerth van Wijk, Netherlands Marc Rothenberg, United States
Lyndon Mansfield, United States Hugh Sampson, United States
Ruby Pawankar, Japan Mario Sánchez Borges, Venezuela
Nelson Rosário Filho, Brazil Dana Wallace, United States
2 WISC 2016 6-9 December 2016 Jerusalem, Israel
Conference Information
KEY REASONS TO ATTEND: OBJECTIVES:
Be on the leading edge of medical education and learning! • To provide insights into the fundamentals and
• Attend state-of-the-art lectures by world experts on mechanisms of allergic/immunologic diseases by
allergy, asthma and clinical immunology reviewing and evaluating the origins and severity of each
disease
• Participate in practical, clinic-friendly workshops on
Immunotherapy, Food Allergy, Anaphylaxis, Skin Allergies, • To highlight the most recent advances in the treatment
Drug Allergy, Asthma, Rhinitis, COPD, Sleep Disorders, and prevention of allergic and immunological diseases
and more • To provide an integrated approach to the diagnosis and
• Network with others in your field and areas of interest management of severe and more complex forms of
including: Asthma, Allergy, Immunology, Pediatrics, allergies
Pulmonology, Ophthalmology, Gastroenterology, • To identify unmet needs and areas of research priorities
Dermatology and ENT
• Showcase your own achievements to key international WHO SHOULD ATTEND:
opinion leaders and interact with international and The Conference will be attended by delegates from all over
regional colleagues the world. Delegates will be specialists, general practitioners,
researchers, and other allied health professionals with
interest in:
• Allergy • Immunology
• Asthma • Ophthalmology
• Dermatology • Pediatrics
• ENT • Pulmonology
• Gastroenterology • Family Practice
Scientific Program Information
CME ABSTRACTS
More information regarding CME will be announced later ABSTRACT SUBMISSION NOW OPEN!
in 2016. Please visit www.worldallergy.org/wisc2016 for WISC 2016 invites you to submit an abstract to be considered
frequent updates. for inclusion in the Scientific Program. Accepted abstracts will
be presented in thematic Poster Sessions.
SESSION TYPES Please visit www.worldallergy.org/wisc2016 to view
PLENARY SESSIONS submission guidelines.
Plenary presentations will set the stage with context and
background through overviews and literature reviews to NOTIFICATION OF ACCEPTANCE
define unmet needs. Notification of acceptance/rejection will be emailed
September 2016. The Presenting Author will receive all
KEYNOTE LECTURES correspondence regarding abstract status, presentation
Keynote Lectures offer attendees the opportunity to attend type, and date and time, via the email that is provided in the
a lecture on a specific topic from one of the key opinion abstract submission.
leaders in the field.
REGISTRATION
SYMPOSIA The Presenting Author must register for WISC 2016.
Symposia will address specific topics, providing the Registration now open!
opportunity for in-depth and detailed exploration.
TRAVEL AND ACCOMMODATIONS
POSTER SESSIONS Abstract presenters are responsible for arranging and
Accepted abstracts will be presented during Poster Sessions. covering all costs related to registration, travel and hotel
Presenting Authors will stand with their posters, answer accommodations.
questions and discuss their research.
TRAVEL GRANTS
Successful awardees must have an accepted WISC 2016
abstract submission (abstract submission notifications will
be sent in September 2016). Awarded Travel Grant funds
are non-transferrable. If you receive an award and your
attendance status for the Conference changes for any
reason, your award is forfeited. Please visit the WISC 2016
website (www.worldallergy.org/wisc2016) for a Travel Grant
application.
WISC 2016 6-9 December 2016 Jerusalem, Israel 3
What-to-Know
DRESS necessarily best, methods or procedures appropriate for
Dress for the Conference is business casual. the medical situations discussed, but rather are intended
to present an approach, view, statement, or opinion of
the faculty that may be helpful to others who face similar
EVENTS situations.
The WAO International Scientific Conference (WISC) 2016
invites delegates to participate in the following special
events. Events have been created to give delegates the
LANGUAGE
opportunity to network. The official language of the Conference is English. All
sessions will be conducted in English.
WISC OPENING CEREMONY*
6 December 2016 NO SMOKING POLICY
18:00 – 19:30 Smoking is not permitted during any meeting activity or
Ussishkin Auditorium, Main Level, ICC Jerusalem event.
*Conference Badge Required
Join fellow delegates, faculty and the WAO Leadership in the PHOTOGRAPHY
Ussishkin Auditorium at the ICC Jerusalem for the Opening By registering to attend WISC 2016, you acknowledge and
Ceremony to launch the Conference. agree that official photographs taken during the Conference
WISC 2016 WELCOME RECEPTION* may be used for future WAO meeting promotional purposes
6 December 2016 and may be shared in the Conference Photo Gallery and post
19:30 – 21:00 event news updates. Please contact the WAO Secretariat if
Agam Foyer, ICC Jerusalem you have any concerns with this policy. Personal photography
*Conference Badge Required is allowed, but please refrain from flash photography during
the sessions.
EVENT TICKETS FOR GUESTS
If you would like to bring a guest to the Opening Ceremony SOCIAL MEDIA
and Welcome Reception, please visit the WISC 2016 WAO’s social media allows you to interact and stay
Registration site to purchase tickets: www.worldallergy.org/ connected with WAO and other attendees before, during and
wisc2016/registration. after the meeting.
Use the hashtag #WISC2016 for your comments, questions,
EXHIBIT HALL photos or to see what everyone else is talking about.
A commercial exhibition will take place during the
Conference on the following dates and times* Twitter: @worldallergy
Facebook: facebook.com/worldallergyorg
6 December 2016: 14:30 - 21:00 LinkedIn: linkedin.com/company/world-allergy-organization
7 December 2016: 10:30 - 17:00 Instagram: @worldallergyorg
8 December 2016: 10:30 – 15:30
*Times are subject to change
VENUE
The venue of WISC 2016 is:
GUESTS AND CHILDREN
Guests and children will not be allowed to attend any portion of ICC Jerusalem - International Convention Center
the Scientific Program or Exhibition of WISC 2016. PO 6001 Jerusalem 9106001
INSURANCE/LIABILITIES AND
DISCLAIMER
WAO will not be held liable for personal injuries or for loss of
or damage to property incurred by participants or guests at
WISC 2016, including those participating in tours and related
events. Participants and guests are encouraged to purchase
insurance to cover loss incurred in the event of cancellation,
medical expenses or damage to or loss of personal effects
when traveling.
WAO cannot be held liable for any hindrance or disruption of
WISC 2016 proceedings arising from natural, political, social
or economic events or other unforeseen incidents beyond its
control. Registration of a participant implies acceptance of
this condition.
The materials presented at this continuing medical education
activity are made available for educational purposes only.
The materials are not intended to represent the only, nor
4 WISC 2016 6-9 December 2016 Jerusalem, Israel
Abstract Submission – Now Open!
Abstract Submission Deadline: 31 July 2016 TRAVEL GRANTS
WISC 2016 invites you to submit an abstract to be considered WAO would like to recognize our Junior Members, by
for inclusion in the WISC 2016 Scientific Program. Accepted extending the opportunity to apply for a Travel Grant to
abstracts will be presented in thematic Poster Sessions on attend WISC 2016. In order to receive a Travel Grant the
6-8 December 2016. individual must:
Online submission is now open. Please visit www. • Be within five (5) years of your latest degree
worldallergy.org/wisc2016 to view submission guidelines and • Or be 35 years of age or younger
to submit an abstract.
• Submit and have accepted an abstract presented at the
NOTIFICATION OF ACCEPTANCE Conference
Notification of acceptance/rejection will be emailed Please visit www.worldallergy.org/wisc2016/scientific-
September 2016. The Presenting Author will receive all program/abstracts to submit your abstract and to review the
correspondence regarding the abstract status, presentation Travel Grant application, guidelines and instructions.
type, date and time, via the email that is provided in the Travel Grant Awardees will receive:
abstract submission.
• Up to three (3) nights’ accommodations at the
Conference appointed hotel
REGISTRATION
The Presenting Author must register for WISC 2016 on/by • Complimentary registration
31 August 2016. Registration may be done online at www. • WAO Certificate of Award as a Travel Grant recipient
worldallergy.org/wisc2016/registration If you have any questions in regards to the abstract or travel
grant please email wisc@worldallergy.org. Travel grant
TRAVEL recipients will be notified in September 2016. We look
Abstract presenters are responsible for arranging and paying forward to your participation at WISC 2016.
for their own registration, travel and hotel accommodations.
Accommodations can be made at www.worldallergy.org/
wisc2016/accommodation
Go Global with the
WAO Junior Members Group
JOIN TODAY!
www.worldallergy.org/juniormembers
Help shape the Who Qualifies to Be a WAO Junior Member?
future of WAO • Working in the field of allergy/clinical immunology
through global • Under 35 years of age or within 5 years of a training program in
advocacy and allergy, asthma, clinical immunology or related field
leadership as a • A current member of a WAO Member Society
Junior Member
The WAO Junior Members Group is a network of young allergists / clinical
immunologists and scientists who interact with WAO to identify the key issues
affecting the world’s up-and-coming allergy practitioners and to advise on ways to
help meet their educational and training needs.
WISC 2016 6-9 December 2016 Jerusalem, Israel 5
Program At-A-Glance
TUESDAY, 6 DECEMBER 2016
8:30 Keynote Lecture
The Mucosal Leukotriene E4 Receptor CysLT3R Regulates Secretion and Responds to the Mast Cell
8:45
9:00
9:15
9:30 Plenary
Mechanisms of Allergenicity
9:45
10:00
10:15
10:30
Coffee Break
10:45
11:00
Workshop
11:15 Can Monoclonal
SLaai Sister Society
Symposium Antibodies Really
11:30 Symposium Symposium:
Symposium Symposium The Microbiome and be Useful Weapons
Development of Allergen Latin American
Mast Cell Diseases Update on Aeroallergens Its Role in Health and in Treating Allergic
11:45 Immunotherapy (AIT) Peculiarities on Allergic
Disease Diseases as They are In
Diseases
12:00 Cancer and Autoimmune
Diseases?
12:15
12:30
12:45
Poster Sessions
13:00
13:15
13:30
13:45 Junior Member Practical
Course ACAAI Sister Society
14:00 Symposium
Symposium Symposium Diagnostic Work-Up of Symposium: Workshop
Aerobiology and Climate
Emerging Cells in Allergy Chronic Urticaria Respiratory Allergies: Expanding the Role of Food Allergy II
14:15 Change
From Skin Test to the Allergist
14:30 Functional Assessment
14:45
15:00
Coffee Break
15:15
15:30
15:45
Symposium
16:00 Symposium Workshop
Mast Cell ICON: Mast Symposium Company Sponsored Sister Society
The Microbiome and A New Frontier for the
Cells in Health and Hereditary Angioedema Symposium Symposium
16:15 Airway Diseases Allergist
Diseases
16:30
16:45
17:00
17:15
17:30
17:45
18:00
18:15 OPENING CEREMONY
(Welcome Reception to immediately follow)
18:30
18:45
19:00
6 WISC 2016 6-9 December 2016 Jerusalem, Israel
Program At-A-Glance
WEDNESDAY, 7 DECEMBER 2016
8:30 Keynote Lecture
Eosinophilic Esophagitis: A Rising Concern
8:45
9:00
9:15
9:30 Plenary
Clinical Aspects of Immunotherapy
9:45
10:00
10:15
10:30
Coffee Break
10:45
11:00
AAAAI Sister Society
11:15 Symposium: Workshop
Symposium
Symposium Symposium New Concepts in the Integrative Allergy:
11:30 Usefulness of
Advances in Pollen Practical Approaches Company Sponsored Immunopathogenesis Complementary
Inflammatory Markers
Forecasting to Predict for the Management of Symposium and Management Approaches within an
11:45 in the Treatment of
Clinical Symptoms Chronic Urticaria of Primary Allergy Asthma Practice:
Asthma
12:00 Immunodeficiencies The USA Experience
12:15
12:30
12:45
Poster Sessions
13:00
13:15
13:30
13:45 Symposium
Navigating the Junior Member
Symposium Symposium
14:00 Symposium Landscape of Practical Course
Mold Allergy: Is it Real What Really Happens Workshop
New and Old Hyper- IgE Angioedema Conditions: Challenge Tests and
and What Do We Do during Food-Triggered Immune Deficiency
14:15 Syndromes Recognition and Desensitization in Food
About It? Anaphylaxis
Management of and Drug Allergy
14:30 Angioedema Subtypes
14:45
15:00
Coffee Break
15:15
15:30
Symposium
15:45 Beyond
Pharmacotherapy: Role KAAACI Sister Society Workshop
16:00 Symposium
Symposium of Lifestyle Modification Company Sponsored Symposium: When Allergy and
Immunodysregulatory
Drug Allergy in Managing Asthma as Symposium Environment and Immune Deficiency
16:15 Disorders
a Human Condition in Respiratory Allergies Meet
16:30 the Age of Technology
and Outcomes
16:45
17:00
WISC 2016 6-9 December 2016 Jerusalem, Israel 7
Program At-A-Glance
THURSDAY, 8 DECEMBER 2016
8:30 Keynote Lecture
The Ubiquitin System in Health and Disease
8:45
9:00
9:15
9:30 Plenary
Atopic Dermatitis
9:45
10:00
10:15
10:30
Coffee Break
10:45
11:00
11:15
Symposium Junior Member Practical TNSACI Sister Society Workshop
11:30 Symposium Symposium
Primary Prevention of Course Symposium: Non-Allergic Rhinitis
Otitis Media with Severe Asthma (COSA
Atopy and Childhood Practical Management of Specific Immunotherapy: (NAR), Cough and
11:45 Effusion Session)
Asthma Anaphylaxis Bench to Bedside Asthma Practice
12:00
12:15
12:30
12:45
Poster Sessions
13:00
13:15
13:30
13:45 CSACI Sister Society
Symposium:
14:00 Symposium Symposium Symposium Anaphylaxis, Birth
Company Sponsored Workshop
Update on Eosinophilic Desensitization to Drugs Asthma in the Elderly Cohorts, Development
Symposium Anaphylaxis
14:15 Gastrointestinal Disease & Anaphylaxis Today and Eosinophils: The
ABC’s of Canadian
14:30 Allergy Research
14:45
15:00
Coffee Break
15:15
15:30
15:45 Junior Member
Symposium Symposium Symposium
Symposium
16:00 Treatment and Symposium Aberrant Inflammation What’s Going on in
Chronic Rhinosinusitis: Sister Society
Management Advances Asthma and Poverty: and Aberrant Immune Allergy and Clinical
From Endotypes to Symposium
16:15 in Ocular Allergy and What Can Be Done? Programming in Early Immunology: Junior
Personalized Treatment
Other Surface Diseases Life Members at the Front
16:30 Line
16:45
17:00
8 WISC 2016 6-9 December 2016 Jerusalem, IsraelProgram At-A-Glance
FRIDAY, 9 DECEMBER 2016
8:30 Keynote Lecture
Perturbing Early Life Microbiota Development and Its Immunologic Consequences
8:45
9:00
9:15
9:30 Plenary
The Next Frontier for Food Desensitization: Alternatives to Oral Immunotherapy
9:45
10:00
10:15
10:30
Coffee
10:45
11:00
11:15
Symposium Junior Member Practical
11:30 Symposium Symposium
Use of Environmental Symposium Course Sister Society
Phenotypes in Chronic Severe Asthma in
Control to Treat Allergic Food Allergy Allergy Immunotherapy: Symposium
11:45 Rhinosinusitis Children
Disorders What, When and How
12:00
12:15
12:30
WISC 2016 6-9 December 2016 Jerusalem, Israel 9WISC 2016 Keynote Speakers
TUESDAY, 6 DECEMBER
The Mucosal Leukotriene E4 Receptor CysLT3R Regulates Secretion and Responds to the Mast Cell |
Frank Austen (United States)
K. Frank Austen attended Amherst College and Harvard Medical School and served his house
staff training years at the Massachusetts General Hospital (MGH). He established an independent
laboratory at the MGH in 1962 and moved to the Robert B. Brigham in 1966 to establish a
Department of Rheumatology and Immunology which evolved into a department of the Brigham
and Women’s Hospital (BWH). After chairing this Department for 25 years, he shifted to the
AstraZeneca Professorship of Respiratory and Inflammatory Diseases. Austen has pioneered
many aspects of innate immunity/inflammation through an in depth focus on the functions and
regulation of arachidonic acid metabolism to the cysteinyl leukotrienes (cysLTs), the pathways for the
development and phenotypic diversity of mast cells, and the pattern recognition path for activation
of the alternative complement activating pathway which also serves to amplify the classical
complement pathway.
Austen was elected to the National Academy of Sciences and to the American Academy of Arts and Sciences in 1974 and as a
foreign member of the Royal Society (UK) in 2004. He has served as President of the American Association of Immunologists,
the American Academy of Allergy, Asthma and Immunology, and the American Association of Physicians.
WEDNESDAY, 7 DECEMBER
Eosinophilic Esophagitis: A Rising Concern | Marc Rothenberg (United States)
Marc Rothenberg is the Director of the Division of Allergy and Immunology at Cincinnati Children’s
Hospital Medical Center (Cincinnati Children’s), a tenured Professor of Pediatrics at Cincinnati
Children’s and the University of Cincinnati College of Medicine (UCCOM), the Founder and Director
of the Cincinnati Center for Eosinophilic Disorders (CCED), and the Founder and Director of the
NIH--‐sponsored, national Consortium of Eosinophilic Disease Researchers (CEGIR). He graduated
summa cum laude with Highest Honors in Chemistry and Biochemistry from Brandeis University. At
Harvard Medical School (HMS), he completed the combined MD/PhD program. His PhD under the
mentorship of Dr. Frank Austen included seminal studies on eosinophil hematopoiesis, identifying
and characterizing the original biology of eosinophilopoeitins, which led to the development
of a new class of drugs (humanized anti--‐IL--‐5). After completing a residency in pediatrics at
Children’s Hospital in Boston, Dr. Rothenberg did a combined fellowship in Allergy/Immunology and
Hematology at Children’s Hospital in Boston. Rothenberg did post--‐doctorate training in the genetics laboratory of Dr. Philip
Leder at HMS, where he cloned the eotaxin chemokine, which opened up a new direction in allergy research. He came to the
UCCOM and Cincinnati Children’s in 1996 and has helped build a top program in pediatric research; his division is a leader
in pediatric allergy and immunology. His research is focused on molecular analysis of allergic inflammation, primarily on the
pathogenesis of eosinophilic gastrointestinal disorders (EGIDs). His laboratory takes multi--‐disciplinary approaches including
the development of preclinical murine models of allergic disease, genetics, genomics, molecular immunology, cellular biology,
and biochemistry.
Dr. Rothenberg’s awards include the 2007 E. Mead Johnson Award from the Society of Pediatric Research, an NIH MERIT
Award in 2010 and he is a member of the Hewlett--‐ Woodmere Alumni Hall of Fame. He is an elected member of the ASCI,
AAP, AAAS and SPR. His publications number over 325. He has served on various review panels for journals and grant agencies
including the NIH, Burroughs Trust, the MRC of the UK and the ISF of Israel. He is an Associate Editor of the Journal of Allergy
and Clinical Immunology, and Mucosal Immunology, and co--‐Section Head of the Allergy and Hypersensitivity Section of
Faculty 1000. He has served a four--‐year term on the Advisory Council of the NIAID. His research has been supported by
numerous sources including the NIH, Human Frontier Science Program Organization, the Burroughs Wellcome Fund, the Dana
Foundation, the US Department of Defense, US--‐Israel Binational Fund, and PCORI. He has trained a myriad of clinical and
research investigators in his own laboratory and also as Program Director and/or Co--‐Principal Investigator of several NIH
training grants including the NIH CTSA KL2, NICHD CHRCDA K12, and NIAID T32.
10 WISC 2016 6-9 December 2016 Jerusalem, IsraelWISC 2016 Keynote Speakers
THURSDAY, 8 DECEMBER
The Ubiquitin System in Health and Disease | Avram Hershko (Israel)
Nobel Laureate in Chemistry (2004)
Avram Hershko was born in 1937 in Hungary and emigrated with his family to Israel in 1950. He
gained his MD (1965) and PhD (1969) from the Hebrew University - Hadassah Medical School of
Jerusalem. After a post-doctoral fellowship at the University of California of San Francisco (1969-72),
he joined the faculty of the Haifa Technion becoming professor in 1980. He is now Distinguished
Professor in the Unit of Biochemistry in the B. Rappaport Faculty of Medicine of the Technion. His
main research interests concern the mechanisms by which cellular proteins are degraded, a formerly
neglected field of study. Hershko and his colleagues showed that cellular proteins are degraded by a
highly selective system. This system tags proteins for destruction by linkage of a protein called
ubiquitin, which had previously been identified in many tissues, as the name suggests, but whose
function was previously unknown. Subsequent work in Hershko’s and many other laboratories has
shown that the ubiquitin system has a vital role in controlling a wide range of cellular processes,
such as the regulation of cell division, signal transduction and DNA repair. Abnormalities in the
ubiquitin system result in diseases such as certain types of cancer. The full range of functions of the ubiquitin system in health
and disease has still to be elucidated.
Hershko was awarded the Nobel Prize in Chemistry (2004) jointly with his former PhD student Aaron Ciechanover and his
colleague Irwin Rose. His many other honors include the Israel Prize for Biochemistry (1994), the Gairdner Award (1999), The
Alfred P. Sloan Prize of the General Motors Cancer Research Foundation (2000), the Lasker Prize for Basic Medical Research
(2000), the Wolf Prize for Medicine (2001) and the Louisa Gross Horwitz Award (2001). Hershko is a member of the Israel
Academy of Sciences (2000) and a Foreign Associate of the US Academy of Sciences (2003).
FRIDAY, 9 DECEMBER
Perturbing Early Life Microbiota Development and Its Immunologic Consequences | Martin J. Blaser
(United States)
Martin J. Blaser is the Muriel and George Singer Professor of Medicine, Professor of Microbiology,
and Director of the Human Microbiome Program at the NYU School of Medicine. He served as
Chair of the Department of Medicine at NYU from 2000-2012. A physician and microbiologist, Dr.
Blaser is interested in understanding the relationships we have with our persistently colonizing
bacteria. His work over 30 years focused on particular organisms, including Campylobacter species
and Helicobacter pylori, which also are model systems for understanding the interactions of
residential bacteria with their human hosts. Over the last 15 years, he has been actively studying
the relationship of the human microbiome with health and with such important diseases as asthma,
obesity, diabetes, and allergies.
Over the course of his career, Dr. Blaser has served as the advisor for a large number of students,
post-doctoral fellows, and junior faculty. He served as President of the Infectious Diseases Society of America, Chair of
the Board of Scientific Counselors of the National Cancer Institute, Chair of the Advisory Board for Clinical Research of the
National Institutes of Health, and on the Scientific Advisory Board of the Doris Duke Charitable Foundation. He was elected
to the National Academy of Medicine and the American Academy for Arts and Sciences. He holds 25 U.S. patents relating to
his research, and has authored over 540 original articles. Recently, he wrote “Missing Microbes”, a book targeted to general
audiences. He now is serving as the Chair of the Presidential Advisory Council for Combating Antibiotic-Resistant Bacteria.
WISC 2016 6-9 December 2016 Jerusalem, Israel 11Preliminary Scientific Program—Tuesday, 6 December KEYNOTE 08.30 – 09.00 The Mucosal Leukotriene E4 Receptor CysLT3R Regulates Secretion and Responds to the Mast Cell | Frank Austen (United States) PLENARY 09.00 – 10.30 Mechanisms of Allergenicity The Evolutionary Roots of Allergenicity | Kathleen Barnes (United States) Recent Discoveries on Molecular Intrinsic Allergenic Properties | Rudolf Valenta (Austria) IgG4 to Environmental Antigens in Healthy and Allergic Children | Paolo Maria Matricardi (Germany) COFFEE BREAK 10.30 – 11.00 SYMPOSIA 11.00 – 12.30 Mast Cell Diseases The Many Faces of Mast Cell Clonal Diseases | Dean Metcalfe (United States) Mast Cell Activation Syndrome | Alon Hershko (Israel) Prognosis and Management of Diseases of Mast Cell Activation and Proliferation | Mariana Castells (United States) Development of Allergen Immunotherapy (AIT) Mechanisms of Early Desensitization: Histamine Receptors and More | Natalija Novak (Germany) Role of B Reg Cells in Allergen Tolerance during Allergen Immunotherapy (AIT) | Mübeccel Akdis (Switzerland) Rapid Suppression of IgE-Mediated Allergy | Fred Finkelman (United States) Update in Aeroallergens Pollen and Fungal Allergens | Jay Portnoy (United States) Mite and Cockroach Allergens | Luis Caraballo (Colombia) Regulatory Aspects of Immunotherapy | Sergio Bonini (United Kingdom) The Microbiome and Its Role in Health Disease Barrier Function and Microbiotic Dysbiosis in Atopic Dermatitis | Michael Levin (South Africa) Early Life Microbiome Dysbiosis and Development of Allergy | Christine Johnson (United States) Late Onset Airway Disease: Role of Viruses and Bacteria | Peter Le Souëf (Australia) WORKSHOP 11.00 – 12.30 Can Monoclonal Antibodies Really be Useful Weapons in Treating Allergic Diseases as they are in Cancer and Autoimmune Diseases? Cancer and Monoclonal Antibodies | Erika Jensen-Jarolim (Austria) Autoimmune Diseases and Monoclonal Antibodies | TBC Allergic Diseases and Monoclonal Antibodies | Francesca Levi-Schaffer (Israel) SISTER SOCIETY SYMPOSIUM 11.00 – 12.30 Latin American Society of Allergy, Asthma and Immunology (SLaai) — Latin American Peculiarities on Allergic Diseases Characteristics of Anaphylaxis Detection and Management | TBC Lessons Learnt from Drug Allergy Registries | TBC Allergic Rhinitis and Its Impact on Asthma (ARIA) Achievements and Future Needs | TBC POSTER SESSIONS 12.30 – 13.30 12 WISC 2016 6-9 December 2016 Jerusalem, Israel
Preliminary Scientific Program—Tuesday, 6 December
SYMPOSIA 13.30 – 15.00
Emerging Cells in Allergy
Role of Mast Cells in Innate Inflammation | Hideaki Morita (Japan)
Lymphoid Cells, Effector Cells and Immune Responses | Judah Denburg (Canada)
Macrophages & Neutrophils | Lorenzo Moretta (Italy)
Aerobiology and Climate Change
Meteorological Conditions, Climate Change, New Emerging Factors, and Asthma and Related Allergic Disorders: A Statement of the World
Allergy Organization | Menachem Rottem (Israel)
Climate Change and Allergic Respiratory Diseases: An Update for the Allergist | Gennaro D’Amato (Italy)
The Role of Aerobiology in 2016 | Jay Portnoy (United States)
Chronic Urticaria
Classification of Chronic Urticaria: New Aspects | David Lang (United States)
Angioedema—Histamine or Bradykinin? | Avner Reshef (Israel)
Treatment of Patients with Severe Chronic Urticaria | Mario Sánchez Borges (Venezuela)
JUNIOR MEMBER PRACTICAL COURSE 13.30 – 15.00
Diagnostic Work-up of Respiratory Allergies: From Skin Test to Functional Assessment
Senior Moderator | TBC
Junior Member | Shira Benor (Israel)
Junior Member | Mariana Couto (Portugal)
WORKSHOP 13.30 – 15.00
Food Allergy II
Diagnosis of Food Allergy | Yael Levy (Israel)
Food Oral Immunotherapy | Yitzhak Katz (Israel)
Baked Milk Immunotherapy | Ilan Dalal (Israel)
SISTER SOCIETY SYMPOSIUM 13.30 – 15.00
American College of Allergy, Asthma and Immunology (ACAAI) Symposium -
Expanding the Role of the Allergist
Ocular Allergy ICON: The Eyes Have It | Leonard Bielory (United States)
Asthma COPD Overlap Syndrome (ACOS) | Bryan Martin (United States)
Provocative Challenges | Stephen Tilles (United States)
COFFEE BREAK 15.00 – 15.30
SYMPOSIA 15.30 – 17.00
Mast Cell ICON: Mast Cells in Health & Diseases
Non-IgE Mediated Mast Cell Activation in Disease | Dean Metcalfe (United States)
Mast Cells Beyond Allergy: T Cell-Mast Cell Interaction in Inflammatory Processes | Yoseph Mekori (Israel)
Mast Cells in Allergic Airway Inflammation | Ruby Pawankar (Japan)
Hereditary Angioedema (HAE)
HAE in the Pediatric Population | Aharon Kessel (Israel)
HAE during Pregnancy | Elias Toubi (Israel)
Treatment of HAE in 2016 | Michael Frank (United States)
The Microbiome and Airway Diseases
The Airway Microbiome: Status and Future | Peter Howarth (United Kingdom)
Allergens and Superallergens: The Immune Proteome of Staphylococcus Aureus | Claus Bachert (Belgium)
Microbial Exposures Influence the Risk for Wheezing and Asthma in Urban Children | James Gern (United States)
WORKSHOP 15.30 – 17.00
A New Frontier for the Allergist
Clinical Pearls for Diagnosing Allergic Contact Dermatitis | David Bernstein (United States)
Skin Tests and Other Provocation Tests in Chronic Urticaria | Marcus Maurer (Germany)
Metal Hypersensitivity and Prosthetic Devices | Karin Pacheco (United States)
WISC 2016 6-9 December 2016 Jerusalem, Israel 13Preliminary Scientific Program—Wednesday, 7 December KEYNOTE 08.30 – 09.00 Eosinophilic Esophagitis: A Rising Concern | Marc Rothenberg (United States) PLENARY 09.00 – 10.30 Clinical Aspects in Immunotherapy The Future Directions in Immunotherapy | Giovanni Passalacqua (Italy) The New Routes of Administration: Where Do We Stand? | Gabriela Senti (Switzerland) Advances in Mechanisms and Clinical Implications | Cezmi Akdis (Switzerland) COFFEE BREAK 10.30 – 11.00 SYMPOSIA 11.00 – 12.30 Advances in Pollen Forecasting to Predict Clinical Symptoms The Relationship between Pollen Concentration and Clinical Symptom Thresholds | Carmi Geller-Bernstein (United States) Validation of Pollen Collection and Monitoring Techniques and Clinical Symptom Instruments for Assessing the Impact of Pollen Exposure on Patient Health | Santiago Martinez (United States) Modeling and Forecasting Pollen for Allergy Prevention | Carsten Skjøth (United Kingdom) Usefulness of Inflammatory Markers in the Treatment of Asthma Novel Aspects of Inflammation in Asthma: Future Approaches | Fernan Caballero-Fonseca (Venezuela) Inflammatory Markers for Asthma Diagnosis and Follow-up | Nelson Rosário Filho (Brazil) Targeted Therapies for Asthma: State of the Art | Walter Canonica (Italy) Practical Approaches for the Management of Chronic Urticaria Mechanisms of Chronic Urticaria: Do We Understand the Whole Landscape? | Jonathan Bernstein (United States) Diagnostic, Quality of Life and Control Tools in Chronic Urticaria | Torsten Zuberbier (Germany) Treatment of Chronic Urticaria, Guidelines and Beyond | Allen Kaplan (United States) WORKSHOP 11.00 – 12.30 Integrative Allergy: Complementary Approaches within an Allergy Asthma Practice What is Integrative Allergy, Integrative Medicine and Complementary and Integrative Medicine (CAM) | William Silvers (United States) Evidence Basis for Integrative Modalities | Leonard Bielory (United States) Stress and Immune System | TBC SISTER SOCIETY SYMPOSIUM 11.00 – 12.30 American Academy of Allergy Asthma & Immulology Symposium - New Concepts in the Immunopathogenesis and Management of Primary Immunodeficiencies Immune Deficiencies Associated with Early Onset Inflammatory Bowel Disease | Kathleen Sullivan (United States) Severe Combined Immune Deficiency: from Newborn Screening to Cellular and Molecular Therapy | Luigi Notarangelo (United States) The Complex Veiled Among the Common Variables - Addressing the Challenges of the new “CVID-like” Disorders | Klaus Warnatz (Germany) POSTER SESSIONS 12.30 – 13.30 SYMPOSIA 13.30 – 15.00 New and Old Hyper-IgE Syndromes Autosomal Dominant Hyper IgE Syndromes (AD-HIES), Phosphoglucomutase 3 (PGM 3) and Dedicator of Cytokinesis 8 (DOCK8) Deficiency | Thomas Fleisher (United States) A Common Monogenic Cause for the Mast Cell Activation Syndrome | Joshua Milner (United States) Hypereosinophilic Syndrome (HES) and Eosinophilic Granulomatosis with Polyangiitis (EGPA) | Michael Wechsler (United States) Mold Allergy: Is It Real and What Do We Do About It? Fungi: What Are They and What Types of Exposure Do We Have to Them? | Estelle Levetin (United States) Health Effects of Fungal Exposure: What is Known | John Cohn (United States) Interventions to Reduce Fungal Exposure and Improve Health | James Sublett (United States) 14 WISC 2016 6-9 December 2016 Jerusalem, Israel
Preliminary Scientific Program—Wednesday, 7 December
Navigating the Landscape of Angioedema Conditions: Recognition and Management of Angioedema Subtypes
Idiopathic Angioedema: Histaminergic and Kinin-Mediated | Konrad Bork (Germany)
C1INH Deficiency: Acquired and Hereditary | TBC
Bradykinin Mediated Angioedema with Normal C1INH–ACE-I and Associated and HAE with Normal C1INH | Bruce Zuraw (United States)
What Really Happens during Food Triggered Anaphylaxis
Who Is at Risk of Food-Triggered Anaphylaxis? | Margitta Worm (Germany)
What Drives Symptoms during Acute Allergic Reactions to Food? | Stanley Fineman (United States)
Cardiovascular Changes during Acute Allergic Reactions to Food | Paul Turner (United Kingdom)
JUNIOR MEMBER PRACTICAL COURSE 13.30 – 15.00
Challenge Tests and Desensitization in Food and Drug Allergy
Senior Moderator | TBC
Junior Member | TBC
Junior Member | TBC
WORKSHOP 13:30 – 15.00
Immune Deficiency
Five Decades of Immune Deficiency: A Story to be Told | Amos Etzioni (Israel)
Primary Immunodeficiency | José Antonio Ortega Martell (Mexico)
Newborn Screening for Severe Combined Immunodeficiency (SCID): State of the Art | Raz Somech (Israel)
COFFEE BREAK 15.00 – 15.30
SYMPOSIA 15.30 – 17.00
Immunodysregulatory Disorders
Inflammasome Related Disorders | Hal Hoffman (United States)
Hereditary Periodic Fever Syndromes | Yackov Berkun (Israel)
Blockers for the Therapy of Auto Inflammatory Diseases | Lanny J. Rosenwasser (United States)
Beyond Pharmacotherapy: Role of Lifestyle Modification in Managing Asthma as Human Condition in the Age of
Technology and Outcomes
The Role of Lifestyles on the Immunology, Physiology, and Quality of Life of Asthma Patients: Is It Time for Artificial Intelligence and Mobile
Health? | Mark Lazarovich (United States)
The Effect of Activity and Weight Modification on Asthma Management | Louis-Philippe Boulet (Canada)
Genetics and Epigenetics of Stress and Asthma | Juan C. Celedon (United States)
Drug Allergy
Beta-Lactam Allergy Evaluation: Do We Have Alternatives? | Luis Felipe Chiaverini Ensina (Brazil)
Desensitization of Biological Drugs | Nancy Agmon-Levin (Israel)
Practical Approach to NSAID Hypersensitivity | Pedro Giavina Bianchi (Brazil)
WORKSHOP 15.30 – 17.00
When Allergy and Immune Deficiency Meet
Eczema and Asthma in Immune Deficiencies | Kathleen Sullivan (United States)
Food Allergies in Immune Deficiencies | Sara Anvari (United States)
The Peculiar Atopy in Hyper IgE Syndromes | Ricardo Sorensen (United States)
SISTER SOCIETY SYMPOSIUM 15.30 – 17.00
Korean Academy of Asthma, Allergy, and Clinical Immunology Symposium (KAAACI)
- Environment and Respiratory Allergies
The Impact of Air Pollutants on Cell Barriers in Asthma| An-Soo Jang (Korea)
Major Environmental Factors in Children with Allergic Rhinitis - The Korean Experience| Dae Hyun Lim (Korea)
Early Life Origins of Respiratory Disease: Lessons from a Birth Cohort | Allan Becker (Canada)
WISC 2016 6-9 December 2016 Jerusalem, Israel 15Preliminary Scientific Program—Thursday, 8 December KEYNOTE 08.30 – 09.00 The Ubiquitin System in Health and Disease | Avram Hershko (Israel) PLENARY 09.00 – 10.30 Atopic Dermatitis Atopic Dermatitis: Epidemiology and Mechanisms State of the Art | TBC Differences between Atopic Dermatitis (AD) Disease Phenotypes and the Need for Personalized Medicine in Atopic Dermatitis | Emma Guttman (United States) Therapy of Atopic Dermatitis | Torsten Zuberbier (Germany) COFFEE BREAK 10.30 – 11.00 SYMPOSIA 11.00 – 12.30 Otitis Media with Effusion Effusion in the Middle Ear: A Hidden Enemy in School Children (Epidemiological Aspects and Impact on Learning) | Yi Li (China) Otitis Media with Effusion (OME) and Atopy: Cause or Myth? (Phsiopathogenic Mechanisms and Relationship) | Nelson Rosário Filho (Brazil) Eosinophlic Otitis Media (Diagnostic and Approach Treatment) | Mario Zernotti (Argentina) Severe Asthma: COSA Session Severe Asthma Phenotypes and Fungal Allergic Respiratory Disease | Paul Greenberger (United States) Aspirin Exacerbated Respiratory Disease | Shmuel Kivity (Israel) Novel Therapies for Severe - Unresponsive Asthma | Elliot Israel (United States) Primary Prevention of Atopy and Childhood Asthma Modulation of Early Life Allergic Sensitization for the Prevention of Childhood Asthma | Robert Wood (United States) New Insights on the Diagnosis and Treatment of Asthma Exacerbation in Infants under the Age of One Year | Benjamin Volovitz (Israel) Vitamins and/or Probiotics Supplementation for Asthma Prevention | Avraham Biegelman (United States) JUNIOR MEMBER PRACTICAL COURSE 11.00 – 12.30 Practical Management of Anaphylaxis Senior Moderator | TBC Junior Member | Vered Schichter-Konfino (Israel) Junior Member | Manuel Rial Prado (Spain) WORKSHOP 11.00 – 12.30 Non-Allergic Rhinitis (NAR), Cough and Asthma Practice Upper and Lower Airways Relationship and Treatment | Eli Meltzer (United States) How Do We Manage Recalcitrant Sinusitis Patients | Michael Kaliner (United States) Impact of Sinonasal Disease on the Lower Airways | Larry Borish (United States) SISTER SOCIETY SYMPOSIUM 11.00 – 12.30 Turkish National Society of Allergy and Clinical Immunology Symposium (TNSACI) - Specific Immunotherapy: Bench to Bedside Skin Prick Testing: Optimizing the Practice | Bülent Şekerel (Turkey) SCIT vs. SLIT: Translation to the Practice in the Real World | Dilşad Mungan (Turkey) Modifying the Immune Response: Specific Immunotherapy | Mübeccel Akdis (Switzerland) POSTER SESSIONS 12.30 – 13.30 16 WISC 2016 6-9 December 2016 Jerusalem, Israel
Preliminary Scientific Program—Thursday, 8 December
SYMPOSIA 13.30 – 15.00
Update on Eosinophilic Gastrointestinal Disease
Epidemiology of EGIDS | Carina Venter (United States)
Pathogenesis of EGIDS | Jonathan Spergel (United States)
Treatment of EGIDS | Ignacio J. Ansotegui (Spain)
Asthma in the Elderly Today
Clinical Features Differentiating Elderly Asthma from Non-Elderly Asthma | Anahi Yañez (Argentina)
Asthma in the Elderly: Role of Comormidities | Arzu Yorgancioglu (Turkey)
What Are the Challengers in Asthma Elderly Treatment? | Sang Heon Cho (Korea)
Desensitization to Drugs & Anaphylaxis
Desensitization to NSAIDS | Pedro Giavina Bianchi (Brazil)
Desensitization to Beta-Lactams | Edgardo Jares (Argentina)
Desensitization to Chemotherapy and Monoclonal Antibodies | Mariana Castells (United States)
WORKSHOP 13:30 – 15.00
Anaphylaxis
Anaphylaxis: Epidemiology and Etiological Factors | Alessandro Fiocchi (Italy)
Food Induced Exercise-Related Anaphylaxis | Stephen Tilles (United States)
The Epipen Device: The Doctor vs. Patient Perspective | Aharon Kessel (Israel)
SISTER SOCIETY SYMPOSIUM 13.30 – 15.00
Canadian Society of Allergy and Clinical Immunology (CSACI) - Anaphylaxis, Birth Cohorts,
Development and Eosinophils: The ABC’s of Canadian Allergy Research
Cross Canada Anaphylaxis Registry (CCARE): Lessons in Anaphylaxis from Montreal and Beyond | Ben Shoshan (Canada)
The CHILD study: Lessons from a Birth Cohort | Allan Becker (Canada)
Allergy is in the Blood at Birth: Cord Blood Eosinophil Progenitors Predict the Development of Allergy and Asthma | Judah Denburg (Canada)
COFFEE BREAK 15.00 – 15.30
SYMPOSIA 15.30 – 17.00
Treatment and Management Advances in Ocular Allergy and Other Surface Diseases
Ocular Overview | Paul Greenberger (United States)
Intranasal Steroids and the Eye: Pros and Cons | Leonard Bielory (United States)
Inflammatory Mediators of the Ocular Surface: Implications in Management | Dana Wallace (United States)
Asthma and Poverty: What Can Be Done?
Epidemiology and Clinical Features of Asthma in the Developing World | Alvaro Cruz (Brazil)
Are GINA Guidelines Useful in Underdeveloped Countries | Arnaldo Caprles-Hulett (Venezuela)
Asthma in the Inner Cities of Developed Countries | Wanda Phipatanakul (United States)
Chronic Rhinosinusitis: From Endotypes to Personalized Treatment
Chronic Rhinosinusitis in Children: Relationship to Adenotonsillar Hypertrophy, Sleep Disordered Breathing and Behavioral Disorders: Role
of the Allergist | Bernard Silverman (United States)
Aspirin Sensitivity (AERD) in Chronic Rhinosinusitis (CRS) | Larry Borish (United States)
Personalized Treatment Approaches: Biologics in CRS | Robert Schleimer (United States)
Aberrant Inflammation and Aberrant Immune Programming in Early Life
Immune-Microbiota Interactions in Early Life: Dysbiosis as a Global Health Issue | Susan Prescott (Australia)
The Microbiome and Allergic Disease | Mimi Tang (Australia)
Feeding Modalities: Long-Term Influence on the Immune Responses to Food and Environmental Allergens | Ricardo Sorensen (United States)
JUNIOR MEMBER SYMPOSIUM 15.30 – 17.00
What’s Going on in Allergy and Clinical Immunology: Junior Members at the Front Line
Patch Testing Procedures: A Consensus Document | Razvigor Darlenski (Bulgaria)
The Joint Junior Members Survey for Better Formation and Education | Marco Caminati (Italy)
New International Classification of Disease (ICD) and Its Clinical Relevance | Luciana Kase Tanno (France)
WISC 2016 6-9 December 2016 Jerusalem, Israel 17Preliminary Scientific Program—Friday, 9 December KEYNOTE 08.30 – 09.00 Perturbing Early Life Microbiota Development and Its Immunologic Consequences | Martin J. Blaser (United States) PLENARY 09.00 – 10.30 The Next Frontier for Food Desensitization: Alternatives to Oral Immunotherapy Oral Immunotherapy with Adjuvants | Wesley Burks (United States) Epicutaneous Desensitization | Hugh Sampson (United States) Multiple Food Desensitization | Motohiro Ebisawa (Japan) COFFEE BREAK 10.30 – 11.00 SYMPOSIA 11.00 – 12.30 Use of Environmental Control to Treat Allergic Disorders Taking on Environmental Health History | Wanda Phipatanakul (United States) Potentially Fatal Occupational Lung Disease | Chester Zeiss (United States) Communicating Findings and Recommending Interventions: What Works? | Adnan Custovic (United Kingdom) Severe Asthma in Children The Definition of Severe Asthma | Bruce Mazer (Canada) Asthma Phenotypes | Leonard Bacharier (United States) When Off-Label Medications could be Prescribed | Peter Le Souëf (Australia) Phenotypes in Chronic Rhinosinusitis Chronic Rhinosinusitis with Nasal Polyps | Robert Schleimer (United States) Chronic Rhinosinusitis without Nasal Polyps | Phillippe Gevaert (Belgium) Chronic Rhinosinusitis Phenotypes: How to Apply in Clinical Practice | Lou Zhang (China) Food Allergy Early Intervention of Peanut Allergy | Gideon Lack (United Kingdom) Component Resolved Diagnosis in Food Allergy | Motohiro Ebisawa (Japan) Microbiome and Food Allergy | David Fleischer (United States) JUNIOR MEMBER PRACTICAL COURSE 11.00 – 12.30 Allergy Immunotherapy: What, When and How Senior Moderator | TBC Junior Member | Orly Ben-Or (Israel) Junior Member | Nana Fenny (United States) 18 WISC 2016 6-9 December 2016 Jerusalem, Israel
Registration
REGISTRATION – NOW OPEN!
Register online at www.worldallergy.org/wisc2016/registration
Registration Fees - USD
On or Before 01 August - 01 October -
Registration Category
31 July 2016 30 September 2016 9 December 2016
Delegate $675.00 $775.00 $875.00
Delegate - Low Income Economy* $400.00 $500.00 $600.00
Fellow-In-Training/Student/Allied Health** $350.00 $450.00 $550.00
All registration payments are charged in USD
*Low-Income Economy Status
If you have questions regarding your country’s income status please email: wisc@worldallergy.org
**Fellow-In-Training, Student and Allied Health
Please note your credentials will need to be verified by the WAO Secretariat before your registration is considered
complete. Acceptable verification can either be a letter on department letterhead confirming your status or a copy of your
valid University/Hospital identification card.
WISC 2016 REGISTRATION INCLUDES: SUBSTITUTION POLICY
• Admission to all Scientific Sessions No substitutions are allowed. Individuals will have to cancel
• Admission to Exhibit Hall their original registration and the new person will have to
create a new registration. Within groups; however, you will
• Admission to Poster Hall be able to do substitutions up until the regular registration
• Certificate of Attendance deadline (30 September 2016). After this date you will be
charged an $85 USD administrative fee per substitution/
• Opening Ceremony and Welcome Reception*
name change.
*Delegates who choose not to attend the Opening Ceremony
For more information on the registration rates and
and Welcome Reception will receive a reduced registration fee
requirements please visit the WISC 2016 registration
website: www.worldallergy.org/wisc2016/registration.
CANCELLATION AND REFUND POLICY:
• Before/on 31 July 2016: Full refund less $85 USD VISA POLICY
administrative fee
WAO will not be held liable if you are unable to receive
• 01 August – 30 September 2016: 50% refund your visa before WISC 2016. Registration refunds will not
• On/after 01 October 2016: No refund be provided if you are unable to attend the Conference due
to not obtaining a visa. Please allow a minimum of 45 days
to complete the visa application process. For visa questions
please email: wisc2016@ortra.com.
WISC 2016 6-9 December 2016 Jerusalem, Israel 19Accommodations
To book your hotel accommodations* for WISC 2016, please visit our website: www.worldallergy.org/wisc2016/
accommodations
*The cut-off date for delegates to make hotel reservations online is Friday, 25 November 2016; published rates are subject to
availability.
Below is the list of hotels which are being offered at a reduced price for WISC 2016 attendees. All accommodations are being
handled by WAO’s appointed Professional Conference Organizer – ORTRA, Ltd. – the official PCO for WISC 2016
Single Rate – USD Double Rate – USD Distance to ICC
Hotels Category
Breakfast included Breakfast included Jerusalem
Standard $163 USD $179 USD
Crowne Plaza Jerusalem 650 m
Deluxe $189 USD $204 USD
Dan Jerusalem Hotel Standard $143 USD $164 USD 4.2 km
Dan Panorama Superior $168 USD $189 USD
3.0 km
Deluxe $197 USD $217 USD
David Citadel Hotel
Superior $311 USD $332 USD 3.2 km
Hotel Yehuda Standard $143 ISD $143 USD 6.9 km
Inbal Jerusalem Hotel Superior New City $235 USD $250 USD 3.3 km
Mamilla Hotel Studio Room $291 USD $311 USD 3.1 km
Prima Park Standard $128 USD $140 USD 1.0 km
Ramada Jerusalem Deluxe $179 UD $189 USD 950 m
Superior $357 USD $377 USD
Waldorf Astoria Jerusalem 3.3 km
Deluxe $367 USD $388 USD
CANCELLATION POLICY
• Cancellations must be requested in writing: wisc2016@ortra.com
• Cancellation Policy: Refund will be made if written notification of cancellation is received by Ortra Ltd. as follows:
- Cancellation received until 5 October, 2016 – Full refund less $100 handling fee
- Cancellation received between 6 October, 2016 – 14 November, 2016 - 50% refund
- Cancellation received from 15 November, 2016 - No refund
*Published rates are subject to hotel availability and are not guaranteed. Published rates shall be offered 3 days pre- and post
official Conference dates (6-9 December 2016) and based on hotel availability only and not guaranteed.
*Dates are subject to change.
20 WISC 2016 6-9 December 2016 Jerusalem, IsraelYou can also read
